| Literature DB >> 30527991 |
Matthias Hammwöhner1, Alicia Bukowska2, Wisnu Mahardika3, Andreas Goette4.
Abstract
Atrial fibrillation (AF) is the most common cause of thromboembolic complications. The risk of suffering a thromboembolic complication correlates with the CHA2DS2-VASc score identifying patients at increased risk. It is based on patient age, prior thromboembolic events, and clinical comorbidities, but not based on pathophysiological changes in different types of atrial cardiomyopathy (ACM) as classified in the expert consensus on ACM published in 2016. The impact of different types of ACM has also been acknowledged in the expert consensus statement on catheter ablation of atrial fibrillation. The aim of this review is to review data on clinical importance of ACMs.Entities:
Keywords: Anticoagulation; Fibrillation; Stroke; Therapy; Thrombogenesis
Mesh:
Substances:
Year: 2018 PMID: 30527991 DOI: 10.1016/j.ijcard.2018.11.121
Source DB: PubMed Journal: Int J Cardiol ISSN: 0167-5273 Impact factor: 4.164